The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market. (TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
Mankind Pharma, a reputed global pharmaceutical firm, upholds a profound commitment to spreading kindness and recognizing exceptional service across diverse professions and industries. In a new video campaign to celebrate International Nurses' Day, Mankind Pharma pays homage to the remarkable individuals whose dedication reflects the
Vaccine’, a reputed peer-reviewed international journal, Publishes Phase-III Results of PNEUBEVAX 14TM BE-PCV-14 can be given safely to infants to prevent Pneumococcal Disease PNEUBEVAX 14TM induced robust & functional serotype specific immune response in infants to 14 serotypes offering broadest serotype coverage of any
Like last year, healthcare featured prominently in President Biden’s State of the Union Address. But unlike in 2023, this speech was different in tone on many topics, including healthcare. In an impassioned address, Biden took on the pharmaceutical industry. Asserting that Americans “pay more for
Full-year revenue from operations up 9% to Rs 3,489 Cr, PAT1 up 12% to Rs 519 Cr Fourth quarter revenue from operations declined 8% year-on-year to Rs. 917 Cr, PAT1 increased 6% to Rs. 189 Cr Syngene International Limited today announced its full-year
This facility manufactures APIs & formulations of oncology and non-oncology products. Granules India Limited, announced that the Company’s Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India has successfully completed the US Food and Drug Administration (FDA) inspection between 8th and 12th April 2024, resulting in zero
Mankind Pharma, one of India's leading pharmaceutical companies, is making strides in enhancing the quality of education in remote areas through its ongoing 'Digital Smart Class' initiative. Under their CSR arm, this comprehensive program has established 220 smart classrooms equipped with cutting-edge technology across government
IVI will complete the technology transfer by 2025 Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international markets SEOUL, Republic of Korea and HYDERABAD, India — The International Vaccine Institute (IVI), an international organization with a mission to discover,
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy Venus Remedies is among the largest Indian exporters of these drugs Ukraine is among the largest countries in Europe and its pharmaceutical market has been witnessing
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF This achievement is an endorsement of Venus Remedies' commitment to delivering top-quality pharmaceutical products worldwide Venus Remedies Limited, a leading global pharmaceutical company, has recently secured
